C4X Discovery Taxonomy3

c4xdiscovery.com · checked 14 Nov 2026

#14 · AI Drug Discovery Software

Visit c4xdiscovery.com ↗ Alternatives C4X Discovery Taxonomy3 vs Benevolent Platform

How it plugs in

—Public API

NoOpen source

NoFree tier

Signal on AI Drug Discovery Software4.5#14 of 33

Near it

All alternatives →

Runs on

Web
Windows
Mac
Linux
iOS
Android

Facts

Website: c4xdiscovery.com
Price: Not published
Free trial: Not stated
Clinical-trial application: PatientSeek is described as supporting clinical-trial design and companion diagnostics.
Collaboration: C4X Discovery describes a Taxonomy3 collaboration with the GEN-COVID Consortium in Italy to examine COVID-19 genetics.
Commercial model: C4X Discovery says its business model includes pre-clinical licensing deals with pharmaceutical companies.
Drug discovery use: The company says Taxonomy3-derived targets can inform drug discovery and biomarker identification.
Genetic analysis: Taxonomy3 uses mathematical analysis of genetic data to identify disease-causing targets.
Headquarters: Leeds, United Kingdom
Omics inputs: PatientSeek uses genetics and other omics analyses to stratify patients.
Partnership contact: The company invites inquiries about strategic collaboration and technology partnership opportunities.
Patient stratification: PatientSeek is a patient-stratification platform powered by Taxonomy3.
Product positioning: C4X Discovery describes itself as a drug discovery company focused on small-molecule medicines for immuno-inflammatory diseases.
Registered office: C4X Discovery lists its registered office in Leeds, United Kingdom.
Taxonomy3 platform: Taxonomy3 is a target-identification platform based on human genetics.

On these boards

AI Drug Discovery Software#14 of 33

Built C4X Discovery Taxonomy3?

Claim the page, then edit your card yourself from your member desk: its name, words, logo, screenshots, plans and links. Your desk shows how many readers open it.

Claim C4X Discovery Taxonomy3